Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AstraZeneca's MEDI-4736 to be studied in immunological subsets of advanced colorectal cancer

Aug. 29, 2014

OncoPep completes financing round to support development of MM vaccine

Aug. 29, 2014

Lilly to initiate clinical study of cancer candidate LY-3164530

Aug. 29, 2014

Innate Pharma's IPH-4102 receives E.U. orphan drug status for cutaneous T-cell lymphoma

Aug. 27, 2014

Patrys plans phase Ib/II study of PAT-SM6 with carfilzomib in multiple myeloma

Aug. 27, 2014

Stanford University begins first-in-human study of Hu5F9-G4 for solid tumors

Aug. 25, 2014

Glenmark Pharmaceuticals to begin IND-enabling studies of new bispecific antibody

Aug. 22, 2014

Emergent BioSolutions and MorphoSys to co-develop bispecific protein for prostate cancer

Aug. 21, 2014

Sinocelltech to conduct phase I study of anti-EGFR antibody in patients with colorectal cancer

Aug. 21, 2014

Altor BioScience receives NCI grant to support bladder cancer trial

Aug. 20, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...